Halki Diabetes Remedy

Diabetes Treatment at Home

Get Instant Access

Allison, D. B., Kaprio, J., Korkeila, M., Koskenvuo, M., Neale, M. C. et al (1996). The heritability of body mass index among an international sample of monozygotic twins reared apart. Int J Obes Relat Metab Disord, 20, 501-506.

Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M. C. et al (2000). The common PPARy Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet, 26, 76-80.

Andreasen, C. H., Mogensen, M. S., Borch-Johnsen, K., Sandbak, A., Lauritzen, T. et al (2008a). Non-replication of genome-wide based associations between common variants in INSIG2 and PFKP and obesity in studies of 18,014 Danes. PLoS ONE, 3, e2872.

Andreasen, C. H., Stender-Petersen, K. L., Mogensen, M. S., Torekov, S. S., Wegner, L. et al (2008b). Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes, 57, 95-101.

Barroso, I., Luan, J., Middelberg, R. P., Harding, A. H., Franks, P. W. et al (2003). Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action. PLoS Biol, 1, E20.

Bauer, F., Elbers, C. C., Adan, R. A., Loos, R. J., Onland-Moret, N. C. et al (2009). Obesity genes identified in genome-wide association studies are associated with adiposity measures and potentially with nutrient-specific food preference. Am J Clin Nutr, [Epub ahead of print].

Benzinou, M., Chèvre, J. C., Ward, K. J., Lecoeur, C., Dina, C. et al (2008a). Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations. Hum Mol Genet, 17, 1916-1921.

Benzinou, M., Creemers, J. W., Choquet, H., Lobbens, S., Dina, C. et al (2008b). Common nonsynonymous variants in PCSK1 confer risk of obesity. Nat Genet, 40, 943-945.

Berentzen, T., Kring, S. I., Holst, C., Zimmermann, E., Jess, T. et al (2008). Lack of association of fatness-related FTO gene variants with energy expenditure or physical activity. J Clin Endocrinol Metab, 93, 2904-2908.

Butler, A. A., Marks, D. L., Fan, W., Kuhn, C. M., Bartolome, M. et al (2001). Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat. Nat Neuroscience, 4, 605-611.

Bouatia-Naji, N., Bonnefond, A., Cavalcanti- Proença, C., Spars0, T., Holmkvist, J. et al (2009). A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet, 41, 89-94.

Cai, G., Cole, S. A., Butte, N., Bacino, C., Diego, V. et al (2006). A quantitative trait locus on chromosome 18q for physical activity and dietary intake in Hispanic children. Obesity, 14, 1596-1604.

Cecil, J. E., Tavendale, R., Watt, P., Hetherington, M. M., Palmer, C. N. (2008). An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med, 359, 2558-2566.

Chambers, J. C., Elliott, P., Zabaneh, D., Zhang, W., Li, Y., Froguel, P. et al (2008). Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat Genet, 40, 716-718.

Clement, K., Vaisse, C., Manning, B. S., Basdevant, A., Guy-Grand, B. et al (1995). Genetic variation in the ß3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med, 333, 352-354.

Dean, M. (2003). Approaches to identify genes for complex human diseases: lessons from Mendelian disorders. Hum Mutat, 22, 261-274.

Deeb, S. S., Fajas, L., Nemoto, M., Pihlajamäki, J., Mykkänen, L. et al (1998). A Pro12Ala substitution in PPARy2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet, 20, 284-287.

Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research, Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. et al (2007). Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science, 316, 1331-1336.

Doria, A., Patti, M. E., and Kahn, C. R. (2008). The emerging genetic architecture of type 2 diabetes. Cell Metab, 8, 186-200.

Esparza, J., Fox, C., Harper, I. T., Bennett, P. H., Schulz, L. O. et al (2000). Daily energy expenditure in Mexican and USA Pima Indians: low physical activity as a possible cause of obesity. Int J Obes (Lond), 24, 55-59.

Farooqi, I. S., Keogh, J. M., Yeo, G. S., Lank, E. J., Cheetham, T. et al (2003). Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. NEngl J Med, 348, 1085-1095.

Farooqi, S., O'Rahilly, S. (2006). Genetics of obesity in humans. Endocr Rev, 27, 710-718.

Fischer, J., Koch, L., Emmerling, C., Vierkotten, J., Peters, T. et al (2009). Inactivation of the Fto gene protects from obesity. Nature, 458, 894-898.

Florez, J. C. (2007). The new type 2 diabetes gene TCF7L2. Curr Opin Clin Nutr Metab Care, 10, 391-396.

Florez, J. C., Burtt, N., de Bakker, P. I., Almgren, P., Tuomi, T. et al (2004). Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. Diabetes, 53, 1360-1368.

Florez, J. C., Jablonski, K. A., Bayley, N., Pollin, T. I., de Bakker, P. I. et al (2006). TCF7L2

polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med, 355, 241-250.

Franks, P. W., Rolandsson, O., Debenham, S. L., Fawcett, K. A., Payne, F. et al (2008). Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations. Diabetologia, 51, 458-463.

Frayling, T. M. (2007). Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet, 8, 657-662.

Frayling, T. M., Timpson, N. J., Weedon, M. N., Zeggini, E., Freathy, R. M. et al (2007). A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science, 316, 889-894.

Gerken, T., Girard, C. A., Tung, Y. C., Webby, C. J., Saudek, V. et al (2007). The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science, 318, 1469-1472.

Gloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A. et al (2003). Large-scale association studies of variants in genes encoding the pancreatic P-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes, 52, 568-572.

Goossens, G. H., Petersen, L., Blaak, E. E., Hul, G., Arner, P. et al (2009). Several obesity-and nutrient-related gene polymorphisms but not FTO and UCP variants modulate postabsorptive resting energy expenditure and fat-induced thermogenesis in obese individuals: the NUGENOB study. Int J Obes, 33, 669-679.

Grant, S. F., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A. et al (2006). Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet, 38, 320-323.

Grarup, N., Urhammer, S. A., Ek, J., Albrechtsen, A., Glumer, C. et al (2006). Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects. Diabetologia, 49, 2097-104.

Gray, J., Yeo, G. S. H., Cox, J. J., Morton, J., Adlam, A. L. et al (2006). Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes, 55, 3366-3371.

Guan, W., Pluzhnikov, A., Cox, N. J., Boehnke, M., International Type 2 Diabetes Linkage Analysis Consortium. (2008). Meta-analysis of 23 type 2 diabetes linkage studies from the International Type 2 Diabetes Linkage Analysis Consortium. Hum Hered, 66, 35-49.

Gudmundsson, J., Sulem, P., Steinthorsdottir, V., Bergthorsson, J. T., Thorleifsson, G. et al (2007). Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet, 39(8):977-983.

Hakanen, M., Raitakari, O. T., Lehtimäki, T., Peltonen, N., Pahkala, K. et al (2009). FTO genotype is associated with body mass index after the age of seven years but not with energy intake or leisure-time physical activity. J Clin Endocrinol Metab, 94, 1281-1287.

Haupt, A., Thamer, C., Staiger, H., Tschritter, O., Kirchhoff, K. et al (2009). Variation in the FTO gene influences food intake but not energy expenditure. Exp Clin Endocrinol Diabetes, II7, 194-197.

Heid, I. M., Vollmert, C., Hinney, A., Döring, A., Geller, F. et al (2005). Association of the 103I MC4R allele with decreased body mass in 7937 participants of two population based surveys. J Med Genet, 42, e21.

Herskind, A. M., McGue, M., S0rensen, T. I., Harvald, B. (1996). Sex and age specific assessment of genetic and environmental influences on body mass index in twins. Int J Obes Relat Metab Disord, 20, 106-113.

Hill, J. O., Wyatt, H. R., Reed, G. W., Peters, J. C. (2003) Obesity and the environment: where do we go from here? Science, 299, 853-855.

Huang, Q. Y., Cheng, M. R., Ji, S. L. (2006). Linkage and association studies of the susceptibility genes for type 2 diabetes. Yi Chuan Xue Bao, 33, 573-589.

Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q. et al (1997). Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell, 88, 131-141.

International Association for the Study of Obesity: (

International HapMap Consortium, Frazer, K. A., Ballinger, D. G., Cox, D. R., Hinds, D. A. et al (2007). A second generation human haplotype map of over 3.1 million SNPs. Nature, 449, 851-861.

Ishihara, H., Takeda, S., Tamura, A., Takahashi, R., Yamaguchi, S. et al (2004). Disruption of the WFS1 gene in mice causes progressive beta-cell loss and impaired stimulus-secretion coupling in insulin secretion. Hum Mol Genet, I3, 1159-1170.

Jackson, R. S., Creemers, J. W., Ohaqi, S., Raffin-Sanson, M. L., Sanders, L. et al (1997). Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet, I6, 303-306.

Jalba M, S., Rhoads, G. G., and Demissie, K. (2008). Association of codon 16 and codon 27 beta 2-adrenergic receptor gene polymorphisms with obesity: a meta-analysis. Obesity, I6, 2096-2106.

Jin, T., and Liu, L. (2008). The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus. Mol Endocrinol, 22, 2383-2392.

Johnson, L., van Jaarsveld, C. H., Emmett, P. M., Rogers, I. S., Ness, A. R. et al (2009). Dietary energy density affects fat mass in early adolescence and is not modified by FTO variants. PLoS One, 4, e4594.

Kaprio, J., Tuomilehto, J., Koskenvuo, M., Romanov, K., Reunanen, A. et al (1992). Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia, 35, 1060-1067.

Köbberling, J., and Tillil, H. (1982). Empirical risk figures for first degree relatives of non-insulin dependent diabetics. In J. Köbberling & R. Tattersall (Eds.), The Genetics of Diabetes Mellitus (pp. 201-209). London: Academic Press.

Kurokawa, N., Young, E. H., Oka, Y., Satoh, H., Wareham, N. J. et al (2008). The ADRB3 Trp64Arg variant and BMI: a meta-analysis of 44 833 individuals. Int J Obes (Lond), 32, 1240-1249.

Lango, H., UK Type 2 Diabetes Genetics Consortium, Palmer, C. N., Morris, A. D., Zeggini, E. et al (2008). Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes, 57, 3129-3135.

Lappalainen, T. J., Tolppanen, A. M., Kolehmainen, M., Schwab, U., Lindström, J. et al (2009). The common variant in the FTO gene did not modify the effect of lifestyle changes on body weight: the Finnish Diabetes Prevention Study. Obesity (Silver Spring), 17, 832-836.

Li, S., and Loos, R. J. (2008). Progress in the genetics of common obesity: size matters. Curr Opin Lipidol, 19, 113-121.

Loos, R. J. (2009). Recent progress in the genetics of common obesity. Br J Clin Pharmacol, 68, 811-829.

Loos, R. J., Lindgren, C. M., Li, S., Wheeler, E., Zhao, J. H. et al (2008). Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet, 40, 768-775.

Loos, R. J., Rankinen, T., Tremblay, A., Pérusse, L., Chagnon, Y. et al (2005). Melanocortin-4 receptor gene and physical activity in the Québec Family Study. Int J Obes, 29, 420-428.

Ludovico, O., Pellegrini, F., Di, P. R., Minenna, A., Mastroianno, S. et al (2007). Heterogeneous effect of peroxisome proliferator-activated receptor gamma2 Ala12 variant on type 2 diabetes risk. Obesity (Silver Spring), 15, 1076-1081.

Luke, A., Guo, X., Adeyemo, A. A., Wilks, R., Forrester, T. et al (2001). Heritability of obesity-related traits among Nigerians, Jamaicans and US black people. Int J Obes Relat Metab Disord, 25, 1034-1041.

Lyon, H. N., Florez, J. C., Bersaglieri, T., Saxena, R., Winckler, W. et al (2006). Common variants in the ENPP1 gene are not reproducibly associated with diabetes or obesity. Diabetes, 55, 3180-3184.

Lyssenko, V., Lupi, R., Marchetti, P., Del Guerra, S., Orho-Melander, M. et al (2007). Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest, 117, 2155-2163.

Maes, H. H., Neale, M. C., and Eaves, L. J. (1997). Genetic and environmental factors in relative body weight and human obesity. Behav Genet, 27, 325-351.

Magi, R., Pfeufer, A., Nelis, M., Montpetit, A., Metspalu, A. et al (2007). Evaluating the performance of commercial whole-genome marker sets for capturing common genetic variation. BMC Genomics, 8, 159.

Manolio, T. A., Brooks, L. D., and Collins, F. S. (2008). A HapMap harvest of insights into the genetics of common disease. J Clin Invest, 118, 1590-1605.

Meyre, D., Bouatia-Naji, N., Vatin, V., Veslot, J., Samson, C. et al (2007). ENPP1 K121Q polymorphism and obesity, hyperglycaemia and type 2 diabetes in the prospective DESIR Study. Diabetologia, 50, 2090-2096.

Meyre, D., Delplanque, J., Chèvre, J. C., Lecoeur, C., Lobbens, S. et al (2009). Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet, 41, 157-159.

Minton, J. A., Hattersley, A. T., Owen, K., McCarthy, M. I., Walker, M. et al (2002). Association studies of genetic variation in the WFS1 gene and type 2 diabetes in U.K. populations. Diabetes, 51, 1287-1290.

Moore, A. F., and Florez, J. C. (2008). Genetic susceptibility to type 2 diabetes and implications for antidiabetic therapy. Annu Rev Med, 59, 95-111.

Nakagawa, T., Ogawa, Y., Ebihara, K., Yamanaka, M., Tsuchida, A. et al (2003). Anti-obesity and anti-diabetic effects of brain-derived neurotrophic factor in rodent models of leptin resistance. Int J Obes Relat Metab Disord, 27, 557-565.

Newman, B., Selby, J. V., King, M. C., Slemenda, C., Fabsitz, R. et al (1987). Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia, 30, 763-768.

Norman, R. A., Thompson, D. B., Foroud, T., Garvey, W. T., Bennett, P. H. et al (1997). Genomewide search for genes influencing percent body fat in Pima Indians: Suggestive linkage at chromosome 11q21-q22. Am J Hum Genet, 60, 166-173.

Pietri-Rouxel, F., Manning, B. S., Gros, J., and Strosberg, A. D. (1997). The biochemical effect of the naturally occurring Trp64 Arg mutation on human beta3-adrenoceptor activity. Eur J Biochem, 247, 1174-1179.

Permutt, M. A., Wasson, J., and Cox, N. (2005). Genetic epidemiology of diabetes. J Clin Invest, 115, 1431-1439.

Prokopenko, I., Langenberg, C., Florez, J. C., Saxena, R., Soranzo, N. et al (2009). Variants in MTNR1B influence fasting glucose levels. Nat Genet, 41, 77-81.

Qi, L., Zhang, C., van Dam, R. M., and Hu, F. B. (2007). Interleukin-6 genetic variability and adiposity: associations in two prospective cohorts and systematic review in 26,944 individuals. J Clin Endocrinol Metab, 92, 3618-3625.

Rampersaud, E., Mitchell, B. D., Pollin, T. I., Fu, M., Shen, H. et al (2008). Physical activity and the association of common FTO gene variants with body mass index and obesity. Arch Intern Med, 168, 1791-1797.

Rankinen, T., Zuberi, A., Chagnon, Y. C., Weisnagel, S. J., Argyropoulos, G. et al (2006). The human obesity gene map: The 2005 Update. Obes Res, 14, 529-644.

Ravussin, E., Valencia, M. E., Esparza, J., Bennett, P. H., and Schulz, O. (1994). Effects of a traditional lifestyle on obesity in Pima Indians. Diabetes Care, 17, 1067-1074.

Ren, D., Zhou, Y., Morris, D., Li, M., Li, Z. et al (2007). Neuronal SH2B1 is essential for controlling energy and glucose homeostasis. J Clin Invest, 117, 397-406.

Reynisdottir, I., Thorleifsson, G., Benediktsson, R., Sigurdsson, G., Emilsson, V., et al (2003). Localisation of a susceptibility gene for type diabetes to chromosome 5q34-q35.2. Am J Hum Genet, 73, 323-335.

Rice, T., Perusse, L., Bouchard, C., and Rao, D. C. (1999). Familial aggregation of body mass index and subcutaneous fat measures in the longitudinal Quebec Family Study. Genet Epidemiol, 16, 316-334.

Riggs, A. C., Bernal-Mizrachi, E., Ohsugi, M., Wasson, J., Fatrai, S. et al (2005). Mice conditionally lacking the Wolfram gene in pancreatic islet beta cells exhibit diabetes as a result of enhanced endoplas-mic reticulum stress and apoptosis. Diabetologia, 48, 2313-2321.

Rios, M., Fan, G., Fekete, C., Kelly, J., Bates, B. et al (2001). Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol, 15, 1748-1757.

Sanchez-Pulido, L., and Andrade-Navarro, M. A. (2007). The FTO (fat mass and obesity associated) gene codes for a novel member of the nonheme dioxygenase superfamily. BMC Biochem, 8, 23.

Sandhu, M. S., Weedon, M. N., Fawcett, K. A., Wasson, J., Debenham, S. L. et al (2007). Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet, 39, 951-953.

Saunders, C. L., Chiodini, B. D., Sham, P., Lewis, C. M., Abkevich, V. et al (2007). Meta-analysis of genome-wide linkage studies in BMI and obesity. Obesity, 15, 2263-2275.

Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y. et al (2007). A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science, 316, 1341-1345.

Scuteri, A., Sanna, S., Chen, W-M., Uda, M., Albai, G. et al (2007). Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLos Genetics, 3, e115.

Shugart, Y. Y., Chen, L., Day, I. N. M., Lewis, S. J., Timpson, N. J. et al (2009). Two British women studies replicated the association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) and BMI. Eur J Hum Genet, 17, 1050-1055.

Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L. et al (2007). A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature, 445, 881-885.

Speakman, J. R., Rance, K. A., and Johnstone, A. M. (2008). Polymorphisms of the FTO gene are associated with variation in energy intake, but not energy expenditure. Obesity, 16, 1961-1965.

Steinthorsdottir, V., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Jonsdottir, T. et al (2007). A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet, 39, 770-775.

Ste Marie, L., Miura, G. I., Marsh, D. J., Yagaloff, K., and Palmiter, R. D. (2000). A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc Natl Acad Sci USA, 97, 12339-12344.

Stunkard, A. J., Foch, T. T., and Hrubec, Z. (1986). A twin study of human obesity. JAMA, 256, 51-54.

Stunkard, A. J., S0rensen, T. I., Hanis, C., Teasdale, T. W., Chakraborty, R. et al (1986). An adoption study of human obesity. NEngl J Med, 314, 193-198.

Stutzmann, F., Vatin, V., Cauchi, S., Morandi, A., Jouret, B. et al (2007). Nonsynonymous polymorphisms in melanocortin-4 receptor protect against obesity: the two facets of a Janus obesity gene. Hum Mol Genet, 16, 1837-1844.

Tan, J. T., Dorajoo, R., Seielstad, M., Sim, X. L., Ong, R. T. et al (2008). FTO variants are associated with obesity in the Chinese and Malay populations in Singapore. Diabetes, 57, 2851-2857.

Thorleifsson, G., Walters, G. B., Gudbjartsson, D. F., Steinthorsdottir, V., Sulem, P. et al (2009). Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet, 41, 18-24.

Timpson, N. J., Emmett, P. M., Frayling, T. M., Rogers, I., Hattersley, A. T. et al (2008). The fat mass- and obesity-associated locus and dietary intake in children. Am J Clin Nutr, 88, 971-978.

Tönjes, A., Scholz, M., Loeffler, M., and Stumvoll, M. (2006). Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals. Diabetes Care, 29, 2489-2497.

Tontonoz, P., and Spiegelman, B. M. (2008). Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem, 77, 289-312.

Umekawa, T., Yoshida, T., Sakane, N., Kogure, A., Kondo, M. et al (1999). Trp64Arg mutation of beta3-adrenoceptor gene deteriorates lipolysis induced by beta3-adrenoceptor agonist in human omental adipocytes. Diabetes, 48, 117-120.

Unoki, H., Takahashi, A., Kawaguchi, T., Hara, K., Horikoshi, M. et al (2008). SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet, 40, 1098-1102.

Van Dam, R. M., Hoebee, B., Seidel, J. C., Schaap, M. M., de Bruin, T. W. et al (2005). Common variants in the ATP-sensitive K+ channel genes KCNJ11 (Kir6.2) and ABCC8 (SUR1) in relation to glucose intolerance: population-based studies and meta-analyses. Diabet Med, 22, 590-598.

van Hoek, M., Dehghan, A., Witteman, J. C., van Duijn, C. M., Uitterlinden, A. G., Oostra, B. A. et al (2008). Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes, 57, 3122-3128.

Vimaleswaran, K. S., Li, S., Zhao, J. H., Luan, J., Bingham, S. A. et al (2009). Physical activity attenuates the body mass index-increasing influence of genetic variation in the FTO gene. Am J Clin Nutr, 90, 425-428.

Wahlen, K., Sjolin, E., and Hoffstedt, J. (2008). The common rs9939609 gene variant of the fat mass and obesity associated gene (FTO) is related to fat cell lipolysis. J Lipid Res, 49, 607-611.

Walston, J., Silver, K., Bogardus, C., Knowler, W. C., Celi, F. S. et al (1995). Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the {beta}3-adrenergic-receptor gene. N Engl J Med, 333, 343-347.

Wang, J., Kuusisto, J., Vanttinen, M., Kuulasmaa, T., and Lindstrom, J. (2007). Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion. Diabetologia, 50, 1192-1200.

Wardle, J., Carnell, S., Haworth, C. M., Farooqi, I. S., O'Rahilly, S. et al (2008). Obesity associated genetic variation in FTO is associated with diminished satiety. J Clin Endocrinol Metab, 93, 3640-3643.

Wardle, J., Llewellyn, C., Sanderson, S., and Plomin, R. (2009). The FTO gene and measured food intake in children. Int J Obes, 33, 42-45.

Weedon, M. N., Shields, B., Hitman, G., Walker, M., McCarthy, M. I. et al (2006). No evidence of association of ENPP1 variants with type 2 diabetes or obesity in a study of 8,089 U.K. Caucasians. Diabetes, 55, 3175-3179.

Wellcome Trust Case Control Consortium. (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 447, 661-678.

Widen, E., Lehto, M., Kanninen, T., Walston, J., Shuldiner, A. R., and Groop, L. C. (1995).

Association of a polymorphism in the {beta}3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med, 333, 348-352.

Willer, C. J., Speliotes, E. K, Loos, R. J., Li, S., Lindgren, C. M. et al (2009). Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet, 4I, 25-34.

Wu, Y., Li, H., Loos, R. J., Yu, Z., Ye, X. et al (2008). Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8 and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes, 57, 2834-2842.

Xiang, Z., Litherland, S. A., Sorensen, N. B., Proneth, B., Wood, M. S. et al (2006). Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous propriomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist. Biochemistry, 45, 7277-7288.

Yamada, T., Ishihara, H., Tamura, A., Takahashi, R., Yamaguchi, S. et al (2006). WFS1-deficiency increases endoplasmic reticulum stress, impairs cell cycle progression and triggers the apoptotic pathway specifically in pancreatic beta-cells. Hum Mol Genet, I5, 1600-1609.

Yasuda, K., Miyake, K., Horikawa, Y., Hara, K., Osawa, H. et al (2008). Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet, 40, 1092-1097.

Young, E. H., Wareham, N. J., Farooqi, S., Hinney, A., Hebebrand, J. et al (2007). The V103I polymorphism of the MC4R gene and obesity: population based studies and meta-analysis of 29,563 individuals. Int J Obes, 3I, 1437-1441.

Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S. et al (2007). Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science, 3I6, 1336-1341.

Zeggini, E., Scott, L. J., Saxena, R., Voight, B. F., Marchini, J. L. et al (2008). Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet, 40, 638-645.

Part VI

Development and the Life Course

Was this article helpful?

0 0
Delicious Diabetic Recipes

Delicious Diabetic Recipes

This brilliant guide will teach you how to cook all those delicious recipes for people who have diabetes.

Get My Free Ebook

Post a comment